Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
作者信息
Xu Bo, Ma Fu-Qiang, He Cong, Wu Zi-Qi, Fan Cun-Yu, Mao He-Rong, Zhang Ji-Xian, Yang Min, Hu Zuo-Wei
机构信息
Hubei University Of Chinese Medicine, Wuhan 430065, China.
Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China, Affiliated Hospital of Hubei University of Traditional Chinese Medicine, Wuhan, 430061, China, Hubei Province Academy of Traditional Chinese Medicine, Wuhan, 430074, China.
出版信息
J Infect. 2022 Feb;84(2):e16-e18. doi: 10.1016/j.jinf.2021.12.020. Epub 2021 Dec 25.
Abstract
摘要
相似文献
1
Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
J Infect. 2022 Feb;84(2):e16-e18. doi: 10.1016/j.jinf.2021.12.020. Epub 2021 Dec 25.
2
Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge.
J Korean Med Sci. 2020 Dec 7;35(47):e418. doi: 10.3346/jkms.2020.35.e418.
3
Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.
Eur Respir J. 2020 Jun 18;55(6). doi: 10.1183/13993003.01217-2020. Print 2020 Jun.
4
Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China.
J Infect Dis. 2021 Nov 16;224(9):1473-1488. doi: 10.1093/infdis/jiab181.
5
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study.
Clin Microbiol Infect. 2021 Jan;27(1):89-95. doi: 10.1016/j.cmi.2020.09.023. Epub 2020 Sep 23.
6
Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
J Infect. 2022 Jan 2. doi: 10.1016/j.jinf.2021.12.040.
7
Caution in interpretation of abnormal carbon monoxide diffusion capacity in COVID-19 patients.
Eur Respir J. 2021 Jan 28;57(1). doi: 10.1183/13993003.03263-2020. Print 2021 Jan.
8
Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China.
JAMA Netw Open. 2021 Sep 1;4(9):e2127403. doi: 10.1001/jamanetworkopen.2021.27403.
9
Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge.
Clin Infect Dis. 2021 Dec 16;73(12):2228-2239. doi: 10.1093/cid/ciab147.
10
Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.
J Rehabil Med. 2020 May 31;52(5):jrm00063. doi: 10.2340/16501977-2694.
引用本文的文献
1
Interpretable machine-learning model for Predicting the Convalescent COVID-19 patients with pulmonary diffusing capacity impairment.
BMC Med Inform Decis Mak. 2023 Aug 29;23(1):169. doi: 10.1186/s12911-023-02192-6.
2
The Short- and Long-Term Clinical, Radiological and Functional Consequences of COVID-19.
Arch Bronconeumol. 2022 Apr;58:32-38. doi: 10.1016/j.arbres.2022.03.006. Epub 2022 Apr 13.
本文引用的文献
1
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
Lancet. 2021 Aug 28;398(10302):747-758. doi: 10.1016/S0140-6736(21)01755-4.
2
Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19.
Platelets. 2021 Nov 17;32(8):1092-1102. doi: 10.1080/09537104.2021.1921721. Epub 2021 May 17.
3
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review.
J Infect. 2021 Jul;83(1):1-16. doi: 10.1016/j.jinf.2021.05.004. Epub 2021 May 14.
4
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
Lancet Respir Med. 2021 Jul;9(7):747-754. doi: 10.1016/S2213-2600(21)00174-0. Epub 2021 May 5.
5
Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia.
Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2975-2989. doi: 10.1161/ATVBAHA.120.315175. Epub 2020 Oct 14.
6
Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery.
EClinicalMedicine. 2020 Aug;25:100463. doi: 10.1016/j.eclinm.2020.100463. Epub 2020 Jul 15.
7
Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.
Circulation. 2020 Sep 22;142(12):1176-1189. doi: 10.1161/CIRCULATIONAHA.120.048488. Epub 2020 Jul 28.
8
Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome.
Blood. 2020 Sep 3;136(10):1169-1179. doi: 10.1182/blood.2020007008.
9
Platelet gene expression and function in patients with COVID-19.
Blood. 2020 Sep 10;136(11):1317-1329. doi: 10.1182/blood.2020007214.
10
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
Zotero 插件